Vyvanse and Weight gain poor - a phase IV clinical study of FDA data
Summary:
Weight gain poor is reported as a side effect among people who take Vyvanse (lisdexamfetamine dimesylate), especially for people who are male, 2-9 old, have been taking the drug for 1 - 6 months also take Ursodiol, and have Short-bowel syndrome.
The phase IV clinical study analyzes which people have Weight gain poor when taking Vyvanse. It is created by eHealthMe based on reports of 28,083 people who have side effects when taking Vyvanse from the FDA, and is updated regularly.
What is Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,872 Vyvanse users. Check the latest studies of Vyvanse.
What is Weight gain poor?
Weight gain poor is found to be associated with 299 drugs and 541 conditions by eHealthMe. Check the latest studies of Weight gain poor.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
28,083 people reported to have side effects when taking Vyvanse.
Among them, 35 people (0.12%) have Weight gain poor.

Among these 35 people:
How long have people been on Vyvanse when they have Weight gain poor? *
- < 1 month: 20 %
- 1 - 6 months: 50 %
- 6 - 12 months: 30 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Weight gain poor when taking Vyvanse? *
- female: 30.3 %
- male: 69.7 %
What is the age of people who have Weight gain poor when taking Vyvanse? *
- 0-1: 0.0 %
- 2-9: 61.9 %
- 10-19: 38.1 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
What are other drugs people take besides Vyvanse? *
- Ursodiol: 5 people, 14.29%
- Vitamin K: 4 people, 11.43%
- Tpn: 4 people, 11.43%
- Fosamax: 4 people, 11.43%
- Imodium: 4 people, 11.43%
- Adderall: 2 people, 5.71%
- Focalin: 2 people, 5.71%
- Zoloft: 2 people, 5.71%
- Genotropin: 1 person, 2.86%
- Clopidogrel: 1 person, 2.86%
What are other side effects people have besides Weight gain poor? *
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 15 people, 42.86%
- Insomnia (sleeplessness): 10 people, 28.57%
- Weight Decreased: 8 people, 22.86%
- Weight Increased: 8 people, 22.86%
- Growth Retardation (delayed growth): 7 people, 20.00%
- Nausea And Vomiting: 5 people, 14.29%
- Weight Fluctuation: 5 people, 14.29%
- Flatulence (flatus expelled through the anus): 5 people, 14.29%
- Mood Swings (an extreme or rapid change in mood): 5 people, 14.29%
- Diarrhea: 5 people, 14.29%
What are the existing conditions these people have? *
- Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 5 people, 14.29%
- Weight Increased: 1 person, 2.86%
- Poor Quality Sleep: 1 person, 2.86%
- Hypersensitivity: 1 person, 2.86%
- Growth Hormone Deficiency: 1 person, 2.86%
- Gilles De La Tourette Syndrome (a condition that causes people to make repeated, quick movements or sounds that they cannot control): 1 person, 2.86%
- Autism Spectrum Disorder (developmental disabilities that can cause significant social, communication and behavioural challenges): 1 person, 2.86%
* Approximation only. Some reports may have incomplete information.
Do you take Vyvanse and have Weight gain poor?
- Check whether Weight gain poor is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Vyvanse:
- Vyvanse (35,872 reports)
Weight gain poor treatments and more:
- Weight gain poor (3,181 reports)
How severe was Weight gain poor and when was it recovered:
Expand to all the drugs that have ingredients of lisdexamfetamine dimesylate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Weight gain poor:
- Weight gain poor (299 drugs)
Browse all the conditions that are associated with Weight gain poor:
- Weight gain poor (541 conditions)
Related publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on lisdexamfetamine dimesylate (the active ingredients of Vyvanse) and Vyvanse (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Advair Diskus 100/50 cause Macular Degeneration? - 3 seconds ago
- Could Carvedilol cause Body Temperature Decreased? - 13 seconds ago
- Nubain vs. Flector, side effect and effectiveness comparison - 16 seconds ago
- Could Celebrex cause Red Blood Cell Count Abnormal? - 21 seconds ago
- Novolin R vs. Janumet, side effect and effectiveness comparison - 22 seconds ago
- Could Advair Diskus 100/50 cause Leukocytoclastic Vasculitis? - 24 seconds ago
- Could Baclofen cause Cartilage Injury? - 29 seconds ago
- Could Bactrim Ds cause Hypertension Aggravated? - 30 seconds ago
- Could Prevacid cause Temporal Arteritis? - 33 seconds ago
- Could Voriconazole cause Antiphospholipid Syndrome? - 39 seconds ago